Search Results

Filter
  • 1-10 of  392 results for ""Deferoxamine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine.

  • Authors : Harringer S; Institute of Inorganic Chemistry, University of Vienna, Waehringer Str. 42, 1090 Vienna, Austria. .; Hejl M

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Carboplatin/Carboplatin/Carboplatin/*pharmacology ; Deferoxamine/Deferoxamine/Deferoxamine/*pharmacology

  • Source: Dalton transactions (Cambridge, England : 2003) [Dalton Trans] 2021 Jun 21; Vol. 50 (23), pp. 8167-8178. Date of Electronic Publication: 2021 May 25.Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101176026 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth.

  • Authors : Lang J; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, & CAS Center for Excellence in Nanoscience , National Center for Nanoscience and Technology of China , 11 Beiyitiao , Zhongguancun , Beijing 100190 , China.; Sino-Danish Center for Education and Research/Sino-Danish College of UCAS , Beijing 100190 , China.

Subjects: Drug Delivery Systems*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Deferoxamine/Deferoxamine/Deferoxamine/*pharmacology

  • Source: ACS nano [ACS Nano] 2019 Feb 26; Vol. 13 (2), pp. 2176-2189. Date of Electronic Publication: 2019 Jan 28.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen.

  • Authors : Meher N; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California 94143, United States.; Seo K

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Boron Compounds/Boron Compounds/Boron Compounds/*pharmacology ; Deferoxamine/Deferoxamine/Deferoxamine/*pharmacology

  • Source: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2021 Nov 24; Vol. 13 (46), pp. 54739-54752. Date of Electronic Publication: 2021 Nov 09.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicity.

  • Authors : Umemura M; Cardiovascular Research Institute, Yokohama City University, Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan. Electronic address: .; Kim JH

Subjects: Antidotes*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*toxicity

  • Source: Journal of pharmacological sciences [J Pharmacol Sci] 2017 Aug; Vol. 134 (4), pp. 203-210. Date of Electronic Publication: 2017 Jul 25.Publisher: Japanese Pharmacological Society Country of Publication: Japan NLM ID: 101167001 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

The iron chelator desferrioxamine synergizes with chemotherapy for cancer treatment.

  • Authors : Wang L; Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, 100050, China; Institute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Deferoxamine/Deferoxamine/Deferoxamine/*therapeutic use ; Iron Chelating Agents/Iron Chelating Agents/Iron Chelating Agents/*therapeutic use

  • Source: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) [J Trace Elem Med Biol] 2019 Dec; Vol. 56, pp. 131-138. Date of Publisher: Gustav Fisher Country of Publication: Germany NLM ID: 9508274 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Controlled synthesis of mixed molecular nanostructures from folate and deferrioxamine-Ga(III) on gold and tuning their performance for cancer cells.

  • Authors : Karimi Shervedani R; Department of Chemistry, University of Isfahan, Isfahan 81746-73441, Islamic Republic of Iran.. Electronic address: .; Yaghoobi F

Subjects: Theranostic Nanomedicine*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*diagnosis

  • Source: Bioelectrochemistry (Amsterdam, Netherlands) [Bioelectrochemistry] 2018 Aug; Vol. 122, pp. 149-157. Date of Electronic Publication: 2018 Mar 28.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100953583 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Deferoxamine inhibits TRAIL-mediated apoptosis via regulation of autophagy in human colon cancer cells.

  • Authors : Moon JH; Biosafety Research Institute, College of Veterinary Medicine, Chonbuk National University, Jeonju, Jeonbuk 561-756, Republic of Korea.; Jeong JK

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Apoptosis/Apoptosis/Apoptosis/*drug effects ; Colonic Neoplasms/Colonic Neoplasms/Colonic Neoplasms/*pathology

  • Source: Oncology reports [Oncol Rep] 2015 Mar; Vol. 33 (3), pp. 1171-6. Date of Electronic Publication: 2014 Dec 18.Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine.

  • Authors : Teixeira KC; Laboratório de Fisiologia e Bioquímica do Exercício/UNESC, Av. Universitaria, 1105 Bairro Universitario, 88806-000 Criciuma, SC, Brazil.; Soares FS

Subjects: Acetylcysteine/Acetylcysteine/Acetylcysteine/*therapeutic use ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*adverse effects ; Antioxidants/Antioxidants/Antioxidants/*therapeutic use

  • Source: Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2008; Vol. 21 (2), pp. 309-16. Date of Electronic Publication: 2007 Aug 29.Publisher: Academic Press Country of Publication: England NLM ID: 9715279 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1094-5539

Record details

×
Academic Journal

Cytotoxicity of dihydroartemisinin toward Molt-4 cells attenuated by N-tert-butyl-alpha-phenylnitrone and deferoxamine.

  • Authors : Chan HW; Department of Bioengineering, Box 355061, University of Washington, Seattle, WA 98195-5061, U.S.A. .; Singh NP

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Artemisinins/Artemisinins/Artemisinins/*pharmacology ; Cyclic N-Oxides/Cyclic N-Oxides/Cyclic N-Oxides/*pharmacology

  • Source: Anticancer research [Anticancer Res] 2013 Oct; Vol. 33 (10), pp. 4389-93.Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Dephosphorylation reactions with deferoxamine, a potential chemical nuclease.

  • Authors : Orth ES; INCT-Catálise, Departamento de Química, Universidade Federal de Santa Catarina, Campus Universitário-Trindade, 88040-900 Florianópolis, SC, Brasil.; Medeiros M

Subjects: 2,4-Dinitrophenol/2,4-Dinitrophenol/2,4-Dinitrophenol/*analogs & derivatives ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*chemistry ; Deferoxamine/Deferoxamine/Deferoxamine/*chemistry

  • Source: The Journal of organic chemistry [J Org Chem] 2011 Dec 16; Vol. 76 (24), pp. 10345-8. Date of Electronic Publication: 2011 Nov 15.Publisher: American Chemical Society Country of Publication: United States NLM ID: 2985193R Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  392 results for ""Deferoxamine""